Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity

Acta Ophthalmol. 2013 Feb;91(1):e74-5. doi: 10.1111/j.1755-3768.2012.02469.x. Epub 2012 Jun 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Gestational Age
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Extremely Premature
  • Infant, Newborn
  • Intravitreal Injections
  • Male
  • Ranibizumab
  • Retinal Neovascularization / blood*
  • Retinal Neovascularization / drug therapy
  • Retinopathy of Prematurity / blood*
  • Retinopathy of Prematurity / drug therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / blood*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Ranibizumab